LAVAL, QC, Aug. 16, 2018 /CNW Telbec/ - Neptune
Technologies & Bioressources Inc. ("Neptune" or the "Company")
(NASDAQ: NEPT) (TSX: NEPT) announces the appointment of Ms. Hélène
F. Fortin to its Board of Directors.
"We are pleased that Ms. Fortin has accepted to join the Board
of Neptune," said John Moretz,
Chairman. "Her extensive experience on the boards of leading public
and private corporations combined with her impressive financial and
governance background, will be extremely beneficial for
Neptune, as we seek to significantly grow our activities in the
multi-billion dollar cannabis market."
Hélène F. Fortin FCPA, FCA, ICD.D-IAS.A has been practicing
public accounting for more than 30 years. A member of CPA Québec,
she lectured in Accounting and Auditing during more than 20 years
at many universities in both the undergraduate and graduate levels.
She was actively involved from 1982 to 2015 with the Canadian
Institute of Chartered Accountants (CPA Canada), on the
Interprovincial Board of Evaluators, and with the Auditing and
Assurance Standards Board during which time the 36 international
standards of auditing were adopted in Canada from 2006 to 2009. She has been serving
on boards of directors of large public and private corporations
since 2003 which provides her with exposure to the best practices
within a wide range of organizations, including Loto Québec, a
Crown Corporation of the Province of Québec, as Chair of the Board
of Directors, UBS Bank (Canada),
Institute of Corporate Directors/Quebec, VoiceAge Corporation, and the federal
department audit committees of the Public Service Commission and of
Agriculture/Agrifood Canada. Former positions include the following
Boards: CBC/Radio-Canada, Hydro-Québec, Infrastructure Québec,
Concordia University and Bellus Health.
She is also actively involved with asset management and
financing/funding strategies in her role as trustee/advisor for
large pension plans, estates, and foundations.
About Neptune Technologies & Bioressources Inc.
Neptune is a health and wellness products company, with more
than 50 years of combined experience in extraction, purification
and formulation of value-added differentiated science-based
products. Currently, the Company develops turnkey nutrition product
solutions available in various unique delivery forms, offers
specialty ingredients such as MaxSimil®, a patented
ingredient that enhances the absorption of lipid-based
nutraceuticals, and a variety of other marine and seed oils.
Leveraging its scientific, technological and innovative expertise,
Neptune is preparing to commence production of products in legal
cannabis markets.
The Company's head office is located in Laval, Quebec.
Forward Looking Statements
Statements in this press release that are not statements of
historical or current fact constitute "forward-looking statements"
within the meaning of the U.S. securities laws and Canadian
securities laws. Such forward-looking statements involve known and
unknown risks, uncertainties, and other unknown factors that could
cause the actual results of Neptune to be materially different from
historical results or from any future results expressed or implied
by such forward-looking statements. In addition to statements which
explicitly describe such risks and uncertainties, readers are urged
to consider statements labeled with the terms "believes," "belief,"
"expects," "intends," "anticipates," "will," or "plans" to be
uncertain and forward-looking. Readers are cautioned not to place
undue reliance on these forward-looking statements, which speak
only as of the date of this press release. Forward-looking
information in this press release includes, but is not limited to,
information or statements about our ability to successfully
develop, produce, supply, promote or generate any revenue from the
sale of any cannabis-based products in the legal cannabis
market.
The forward-looking statements contained in this press release
are expressly qualified in their entirety by this cautionary
statement and the "Cautionary Note Regarding Forward-Looking
Information" section contained in Neptune's latest Annual
Information Form (the "AIF"), which also forms part of Neptune's
latest annual report on Form 40-F, and which is available on SEDAR
at www.sedar.com, on EDGAR at www.sec.gov/edgar.shtml and on the
investor section of Neptune's website at www.neptunecorp.com. All
forward-looking statements in this press release are made as of the
date of this press release. Neptune does not undertake to update
any such forward-looking statements whether as a result of new
information, future events or otherwise, except as required by law.
The forward-looking statements contained herein are also subject
generally to other risks and uncertainties that are described from
time to time in Neptune public securities filings with the
Securities and Exchange Commission and the Canadian securities
commissions. Additional information about these assumptions and
risks and uncertainties is contained in the AIF under "Risk
Factors" and in our MD&A for the financial year ended
March 31, 2018 under "Risks and
uncertainties".
Neither NASDAQ nor the Toronto Stock Exchange accepts
responsibility for the adequacy or accuracy of this release.
View original content with
multimedia:http://www.prnewswire.com/news-releases/neptune-announces-appointment-of-helene-f-fortin-to-its-board-of-directors-300698075.html
SOURCE Neptune Technologies & Bioresources inc.